Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration (TREND)


Jan, 2018

Clinical Trial

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.

Silva R, Berta A, Larsen M, Macfadden W, Feller C, Monés J; TREND Study Group.

Ophthalmology. 2018 Jan;125(1):57-65.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive